Ebola has struck the northern part of the Democratic Republic of Congo, but authorities say it is not the same strain as in West Africa.
As West Africa's Ebola toll climbed by 142 cases and 77 deaths, the WHO conceded that the size of the epidemic has been underestimated.
It's time to reassess strategies for controlling methicillin-resistant Staphylococcus aureus (MRSA) in hospitals, mainly because of poor evidence for the efficacy of screening and isolation, which have been regarded as the gold-standard approach, say three German and Swiss experts writing in The Lancet.
The WHO voiced concern about Ebola-related bans on flights to outbreak countries and other African nations.
As deaths top 1,000, a panel says it's ethical to use unlicensed drugs, vaccines.
In recent days, Guinea closed its borders, and suspected cases in Canada and Saudi Arabia were ruled out.
Along with the agency's declaration came an emergency committee's list of steps to limit disease spread.
The Obama administration is setting up an Ebola working group to consider making policy for the possible use of experimental drugs in West Africa's Ebola epidemic, Reuters reported yesterday, while the Food and Drug Administration (FDA) lifted a barrier to the potential use of an unlicensed drug made by a Canadian company.
An official of a leading aid group asserts that inaction by the rest of the world has let the disease get out of control.
Liberia and Sierra Leone have taken new actions to curb infections, as response activities and testing of possible travel-related cases play out on other continents.
